INTERNATIONAL PATENT: BLESS BIOTHERAPEUTICS INC., 주식회사 블레스바이오테라퓨틱스 FILES APPLICATION FOR "COMPOSITION FOR INDUCING DIFFERENTIATION OF CRANIAL NEURAL CREST STEM CELLS INTO PERICYTES, METHOD FOR PRODUCING PERIVASCULAR CELLS FROM CRANIAL NEURAL CREST STEM CELLS AND CELL THERAPEUTIC AGENT COMPOSITION FOR PREVENTING OR TREATING BRAIN NERVOUS SYSTEM DISEASES USING SAME PERIVASCULAR CELLS OR BONE DISEASES USING SAME CRANIAL NEURAL CREST STEM CELLS"

GENEVA, Nov. 11 -- BLESS BIOTHERAPEUTICS INC. (601-B159, 147 Nojak-ro,Hwaseong-si,Gyeonggi-do 18455), 주식회사 블레스바이오테라퓨틱스 (경기도화성시노작로 147, 601-비159호) filed a patent application (PCT/KR2025/006028) for "COMPOSITION FOR INDUCING DIFFERENTIATION OF CRANIAL NEURAL CREST STEM CELLS INTO PERICYTES, METHOD FOR PRODUCING PERIVASCULAR CELLS FROM CRANIAL NEURAL CREST STEM CELLS, AND CELL THERAPEUTIC AGENT COMPOSITION FOR PREVENTING OR TREATING BRAIN NERVOUS SYSTEM DISEASES USING SAME PERIVASCULAR CELLS OR BONE DISEASES USING SAME CRANIAL NEURAL CREST STEM CELLS" on May 02, 20...